Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 39.65
+0.10 (0.25%)
Oct 28, 2026, 1:30 PM CST
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 51.96 billion as of October 28, 2026. It is the 7,641st most valuable company in the world and the 222nd biggest in Taiwan. Its market cap has increased by 142.13% in one year.
Market Cap
51.96B
Enterprise Value
50.27B
Revenue
28.93M
Global Rank
Country Rank
#222 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 51.96B, an increase of 835.14%. That is a compound annual growth rate of 133.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 51.96B | 158.99% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 134.75B |
| Caliway Biopharmaceuticals | 114.79B |
| Oneness Biotech | 23.09B |
| CHO Pharma | 23.01B |
| Sunmax Biotechnology | 21.54B |
| Medigen Vaccine Biologics | 16.77B |
| TaiMed Biologics | 16.69B |
| Ever Supreme Bio Technology | 15.31B |